We are live on ! Find out more
NG

NatWest Group Portfolio holdings

AUM $462M
1-Year Est. Return 47.31%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+47.31%
3 Year Est. Return
+185.58%
5 Year Est. Return
+231.38%
10 Year Est. Return
+745.17%
AUM
$7.61B
AUM Growth
+$7.6B
Cap. Flow
-$540M
Cap. Flow %
-7.1%
Top 10 Hldgs %
79.06%
Holding
474
New
33
Increased
103
Reduced
265
Closed
37

Sector Composition

Rank Sector Weight
1 Financials 75.93%
2 Healthcare 3.3%
3 Technology 3.3%
4 Industrials 2.75%
5 Communication Services 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
226
IQVIA
IQV
$34.7B
$949K 0.01%
14,168
+1,002
+8% +$63.2K
CME icon
227
CME Group
CME
$92.2B
$947K 0.01%
10,000
-52
-0.5% -$4.82K
CLDX icon
228
Celldex Therapeutics
CLDX
$2.77B
$939K 0.01%
+2,246
New +$803K
NSC icon
229
Norfolk Southern
NSC
$78.8B
$936K 0.01%
9,095
-647
-7% -$69.2K
EBAY icon
230
eBay
EBAY
$48.6B
$914K 0.01%
37,631
+7,389
+24% +$176K
VRTX icon
231
Vertex Pharmaceuticals
VRTX
$121B
$904K 0.01%
7,664
+4,961
+184% +$594K
TXT icon
232
Textron
TXT
$16.6B
$873K 0.01%
19,700
-1,980
-9% -$86.1K
XLE icon
233
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$871K 0.01%
22,448
-100
-0.4% -$3.87K
CIG icon
234
CEMIG Preferred Shares
CIG
$6.09B
$860K 0.01%
412,706
-158,510
-28% -$346K
TBAR
235
DELISTED
ROYAL BANK OF SCOTLAND PLC RBS GOLD TRENDPILOT ETN (NL)
TBAR
$859K 0.01%
36,000
-846,825
-96% -$20.6M
REGN icon
236
Regeneron Pharmaceuticals
REGN
$68.8B
$858K 0.01%
1,900
+321
+20% +$136K
BMRN icon
237
BioMarin Pharmaceuticals
BMRN
$11.5B
$857K 0.01%
6,873
-1,402
-17% -$149K
PX
238
DELISTED
Praxair Inc
PX
$856K 0.01%
7,091
+1,279
+22% +$160K
INCY icon
239
Incyte
INCY
$23.5B
$845K 0.01%
9,218
-2,425
-21% -$200K
AKRX
240
DELISTED
Akorn Inc
AKRX
$841K 0.01%
17,697
-4,123
-19% -$187K
UTHR icon
241
United Therapeutics
UTHR
$26.3B
$838K 0.01%
4,857
+177
+4% +$27K
EWT icon
242
iShares MSCI Taiwan ETF
EWT
$10B
$833K 0.01%
26,433
IWF icon
243
iShares Russell 1000 Growth ETF
IWF
$122B
$832K 0.01%
33,652
NVAX icon
244
Novavax
NVAX
$1.23B
$831K 0.01%
+5,021
New +$815K
PTR
245
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$824K 0.01%
7,409
+2,900
+64% +$321K
AFL icon
246
Aflac
AFL
$63.9B
$821K 0.01%
25,668
-508
-2% -$15.5K
F icon
247
Ford
F
$57.3B
$819K 0.01%
50,793
-10,560
-17% -$167K
ALXN
248
DELISTED
Alexion Pharmaceuticals
ALXN
$819K 0.01%
4,725
+1,057
+29% +$191K
TGT icon
249
Target
TGT
$62.1B
$814K 0.01%
9,923
+186
+2% +$14.4K
MDVN
250
DELISTED
MEDIVATION, INC.
MDVN
$814K 0.01%
12,608
+236
+2% +$13.5K

Similar funds

NatWest Group's Q1 2015 Portfolio in Review

As of Q1 2015, NatWest Group held 474 positions worth $7.61B, up 64,485% from $11.8M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

NatWest Group withdrew a net $540M in Q1 2015, closing 37 positions and reducing 265 holdings. Its most notable exit was Allergan Inc, an estimated $6.28K position sold in full.

By sector, the portfolio is most concentrated in Financials at 76% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.

Against the trend, NatWest Group opened a new position in NVIDIA worth $8.9M.

  • NatWest Group's largest Q1 2015 buy was NVIDIA: 17,021,280 shares worth $8.9M.
  • NatWest Group added most to iShares MSCI Emerging Markets ETF in Q1 2015, an estimated $47.1M increase.
  • NatWest Group's biggest Q1 2015 reduction was Citizens Financial Group, cutting an estimated $381M.
  • NatWest Group fully exited Allergan Inc in Q1 2015, selling an estimated $6.28K.
  • NatWest Group's ten largest holdings make up 79% of its $7.61B portfolio in Q1 2015.
  • NatWest Group opened 33 new positions and closed 37 in Q1 2015.
  • NatWest Group's portfolio value rose 64,485% quarter-over-quarter to $7.61B.

Based on NatWest Group's 13F filing for Q1 2015, filed 14 May 2015.